https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Vaccine effectiveness. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/ Tue, 01 Sep 2026 00:00:00 GMT These aggregated results guide international immunization planning and highlight structural improvements needed for future outbreak responses, such as unified research methodologies and integrated health databases. COVID-19 SARS Vaccination Vaccine effectiveness Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129009-9ffc71a1/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129009-9ffc71a1/ Tue, 01 Sep 2026 00:00:00 GMT Findings support continued COVID-19 vaccine recommendations, demonstrating protection across the 2024-2025 season for adults including those with underlying medical conditions. COVID-19 Influenza Vaccination Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-3390-tropicalmed11090244-c76236d8/ https://globalinfectiousdisease.com/research/articles/10-3390-tropicalmed11090244-c76236d8/ Wed, 26 Aug 2026 00:00:00 GMT The article frames precision vaccinology as relevant to mpox preparedness and development of vaccines intended to provide durable, clade-specific protection. The supplied abstract does not provide clinical effectiveness estimates or outcome data supporting a specific public health intervention. Monkeypox Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129078-1790fd72/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129078-1790fd72/ Tue, 25 Aug 2026 00:00:00 GMT The findings suggest that routine one-dose MCV delivery alone is insufficient to reach the measles population-immunity threshold under the model's central assumptions, and that sustained two-dose routine immunisation, high-reach SIAs, and restored immunisation-system capacity may be required. Measles Vaccination Outbreak investigation Surveillance Transmission dynamics Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080717-24db60bc/ https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080717-24db60bc/ Thu, 20 Aug 2026 00:00:00 GMT The authors frame the findings as relevant to vaccination policy, arguing that controlling for healthy-vaccinee bias is important when comparing vaccine effectiveness and that, during a period of high vaccine availability and COVID-19 mortality, Moderna was associated with lower COVID-19 mortality than Pfizer. A higher Moderna dose is suggested as a possible explanation. COVID-19 Vaccination Vaccine effectiveness Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1846269-4100e280/ https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1846269-4100e280/ Wed, 19 Aug 2026 00:00:00 GMT Findings support self-collected nasal swabs as a feasible surveillance option that may enable earlier sampling and higher pathogen detection, particularly when collected within 7 days of symptom onset. Influenza Surveillance Vaccination Vaccine effectiveness Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01549-y-025f7ccf/ https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01549-y-025f7ccf/ Tue, 18 Aug 2026 00:00:00 GMT The reported durability and breadth of the cellular response suggest a potential strategy to overcome the immune evasion and waning protection associated with current spike-focused immunizations. COVID-19 SARS MERS Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080711-df070019/ https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080711-df070019/ Tue, 18 Aug 2026 00:00:00 GMT Seasonal influenza vaccination provided substantial protection against severe respiratory outcomes in a high-risk population with COPD, supporting vaccination as a public health intervention in this group. Influenza Vaccination Vaccine effectiveness Surveillance Journal article https://globalinfectiousdisease.com/research/articles/10-1111-irv-70303-d7a345bf/ https://globalinfectiousdisease.com/research/articles/10-1111-irv-70303-d7a345bf/ Thu, 06 Aug 2026 00:00:00 GMT The findings indicate that seasonal influenza vaccination provided meaningful protection against hospitalisation in 2024/25, with the largest benefit observed in children, supporting continued vaccination efforts in Northern Ireland. Influenza Vaccination Surveillance Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109047-cef9afc2/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109047-cef9afc2/ Sat, 01 Aug 2026 00:00:00 GMT Monkeypox infection and smallpox vaccination may provide cross-protection against orthopoxviruses. Early IgA detection could support mpox diagnosis in asymptomatic high-risk individuals, and complement-dependent neutralization assays may improve cross-immunity assessment. Smallpox Monkeypox Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128786-fdce4611/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128786-fdce4611/ Sat, 01 Aug 2026 00:00:00 GMT The findings demonstrate that KP.2 vaccine provides meaningful but short-lived protection against COVID-19 hospitalization in older adults, informing vaccination timing and booster strategies for this vulnerable population. COVID-19 SARS Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128837-65ea5faf/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128837-65ea5faf/ Sat, 01 Aug 2026 00:00:00 GMT Persistent malaria transmission may erode long-term humoral immunity to pertussis following natural infection, with potential implications for pertussis control strategies and booster vaccination scheduling in malaria-endemic regions. Malaria Pertussis Vaccination Transmission dynamics Surveillance Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128838-7867d6e4/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128838-7867d6e4/ Sat, 01 Aug 2026 00:00:00 GMT The abstract identifies increased use of the two-dose schedule, evaluation of the vaccination interval, and possible inclusion of varicella vaccine in national programs as measures that could reduce breakthrough infections. These implications are the authors' conclusions and are not independently validated by the supplied evidence. Varicella Vaccination Surveillance Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128842-36d8c80c/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128842-36d8c80c/ Sat, 01 Aug 2026 00:00:00 GMT The synthesized data supply real-world effectiveness metrics that inform health policy regarding vaccine deployment across varied clinical risk categories and aging populations. Zoster Vaccination Vaccine effectiveness Health policy Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128857-f9db4a24/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128857-f9db4a24/ Sat, 01 Aug 2026 00:00:00 GMT The adaptable architecture of this delivery mechanism supports future development of combined immunizations targeting multiple vivax malaria components, aligning with broader disease control objectives. Malaria Plasmodium vivax malaria Vaccination Vaccine effectiveness Transmission dynamics Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128858-16db05e0/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128858-16db05e0/ Sat, 01 Aug 2026 00:00:00 GMT The discussion is relevant to accelerating ethically acceptable evaluation of Nipah and other outbreak vaccines, including the role of early and sustained community engagement across epidemic and inter-epidemic periods. Ebola Hemorrhagic Fever Vaccination Vaccine effectiveness Outbreak investigation Transmission dynamics Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128863-a285187d/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128863-a285187d/ Sat, 01 Aug 2026 00:00:00 GMT Waning immunity following acellular pertussis vaccination has been observed in pertussis outbreaks, creating a need for more effective acellular pertussis vaccines. The findings support the potential use of this 2-component vaccine as a pertussis booster in adults. Pertussis Diphtheria Tetanus Vaccination Vaccine effectiveness Randomised controlled trial https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128868-6b4dc9ed/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128868-6b4dc9ed/ Sat, 01 Aug 2026 00:00:00 GMT The findings provide context on observed hospitalization and mortality patterns among laboratory-confirmed Omicron cases according to documented prior immunity profiles in this Iranian registry population. The analysis does not estimate protection against acquiring infection. SARS COVID-19 Vaccination Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128869-4c6119c4/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128869-4c6119c4/ Sat, 01 Aug 2026 00:00:00 GMT These outcomes reinforce the utility of existing immunization protocols for youth amid evolving viral genetics, highlighting the need for longitudinal tracking as alternative delivery methods gain traction. Influenza H5N1 Vaccination Vaccine effectiveness Surveillance Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128872-2b61a135/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128872-2b61a135/ Sat, 01 Aug 2026 00:00:00 GMT The research addresses ongoing challenges in seasonal influenza prevention by exploring an alternative manufacturing approach that may broaden cross-strain coverage. While promising for future therapeutic pipelines, the results remain confined to animal models and require further validation before public health implementation. Influenza Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128882-ce2fe6ce/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128882-ce2fe6ce/ Sat, 01 Aug 2026 00:00:00 GMT The findings suggest mRNA-1345 provides substantial real-world protection against RSV-related hospitalization and healthcare utilization in older adults, supporting the vaccine's value for reducing RSV disease burden in high-risk populations. SARS COVID-19 Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128911-882d461e/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128911-882d461e/ Sat, 01 Aug 2026 00:00:00 GMT The findings provide experimental evidence that Likh1-/- may warrant further investigation as an immunoprophylactic approach for visceral leishmaniasis. The supplied evidence is limited to an animal model and does not establish effectiveness, safety, or feasibility in humans. Leishmaniasis Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128934-45e5ca27/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128934-45e5ca27/ Sat, 01 Aug 2026 00:00:00 GMT Scaling up advanced immunization protocols for senior citizens may reduce seasonal disease burden and alleviate pressure on medical facilities during peak viral circulation periods. Influenza Vaccination Vaccine effectiveness Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128936-0b54e812/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128936-0b54e812/ Sat, 01 Aug 2026 00:00:00 GMT The modeling results suggest that integrating adult demographics into future immunization campaigns could optimize resource allocation and disease reduction in highly affected regions. Policymakers might consider these economic parameters when planning next-generation preventive tools against this parasitic infection. Schistosomiasis Vaccination Vaccine effectiveness Treatment Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128956-49377254/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128956-49377254/ Sat, 01 Aug 2026 00:00:00 GMT The findings provide comparative context for interpreting seasonal influenza vaccine-effectiveness estimates across periods and age groups. The abstract indicates that factors other than population immunity could account for the observed differences, so the results do not establish a single explanation. COVID-19 Influenza H5N1 Vaccination Vaccine effectiveness Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00081-2-4c45715c/ https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00081-2-4c45715c/ Sat, 01 Aug 2026 00:00:00 GMT The findings could inform immunological evaluation of RTS,S/AS01E by identifying antibody durability and maintenance, rather than peak responses alone, as potentially relevant correlates of vaccine efficacy. Malaria Vaccination Treatment Vaccine effectiveness Randomised controlled trial https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taag065-7be8baca/ https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taag065-7be8baca/ Wed, 22 Jul 2026 00:00:00 GMT Inconsistent international protocols complicate clinical counseling and traveler preparedness for dengue-endemic destinations. Harmonizing future advisories will likely depend on supplementary effectiveness data targeting specific demographic groups currently underrepresented in clinical trials. Maintaining transparent dialogue between providers and patients remains critical amid these policy discrepancies. Dengue Vaccination Travel medicine Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag437-411559fa/ https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag437-411559fa/ Tue, 14 Jul 2026 00:00:00 GMT The study provides a U.S. outpatient VE estimate for the 2024–2025 season, indicating vaccination reduced the risk of outpatient medically attended influenza by roughly one-third despite the predominance of A(H1N1)pdm09 and A(H3N2) viruses. Influenza Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01497-7-cbf6a801/ https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01497-7-cbf6a801/ Wed, 08 Jul 2026 00:00:00 GMT Successful stabilization and scalable preparation of this candidate could streamline the transition from laboratory research to regulated clinical testing for filarial disease prevention. Filariasis Treatment Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13803-8-cf9a44fe/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13803-8-cf9a44fe/ Sat, 13 Jun 2026 00:00:00 GMT The findings address vaccine-preventable PCC burden in a high-risk age group during the first post-pandemic season and are positioned as input for vaccination policy, communication, and clinical decision-making. COVID-19 SARS Vaccination Vaccine effectiveness Health policy Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-s2214-109x-26-00017-3-75b4e89a/ https://globalinfectiousdisease.com/research/articles/10-1016-s2214-109x-26-00017-3-75b4e89a/ Mon, 08 Jun 2026 00:00:00 GMT Policymakers must integrate these operational hurdles into immunization planning to prevent systematic exclusion of younger demographics from emerging therapeutic protections. Tuberculosis Vaccination Vaccine effectiveness Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108569-f796b9f3/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108569-f796b9f3/ Mon, 01 Jun 2026 00:00:00 GMT Persistent dosing shortfalls and notable attrition between sequential administrations underscore the necessity for targeted programmatic refinements to maintain community protection against viral circulation. Measles Vaccination Vaccine effectiveness Systematic review https://globalinfectiousdisease.com/research/articles/10-2471-b09772-e19a270b/ https://globalinfectiousdisease.com/research/articles/10-2471-b09772-e19a270b/ Thu, 28 May 2026 00:00:00 GMT The guidance addresses vaccine deployment decisions during a declared international health emergency and reinforces reliance on core public health measures while calling for accelerated development and evaluation of Bundibugyo-specific and broadly protective filovirus vaccines. Ebola Vaccination Surveillance Outbreak investigation Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2516491-76f08689/ https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2516491-76f08689/ Thu, 07 May 2026 00:00:00 GMT This work evaluates an alternative antigen presentation technology aimed at addressing ongoing respiratory disease burdens in aging populations. Successful validation of this platform could inform future immunization strategies targeting groups with historically reduced vaccine responsiveness. Influenza Vaccination Vaccine effectiveness Treatment Randomised controlled trial https://globalinfectiousdisease.com/research/articles/10-3390-pathogens15050503-22c8f2aa/ https://globalinfectiousdisease.com/research/articles/10-3390-pathogens15050503-22c8f2aa/ Thu, 07 May 2026 00:00:00 GMT The data demonstrate significant disease reduction potential through routine immunization, though they simultaneously reveal substantial gaps in current community participation that warrant expanded promotional strategies. Tick-borne encephalitis Vaccination Vaccine effectiveness Surveillance Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106719-705b2901/ https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106719-705b2901/ Wed, 01 Apr 2026 00:00:00 GMT The documented high protection rate suggests utility for national immunization programs aiming to reduce severe bacterial enteric disease in endemic regions. Typhoid fever Vaccination Vaccine effectiveness Treatment Surveillance Case-control study https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14020164-205efd10/ https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14020164-205efd10/ Tue, 10 Feb 2026 00:00:00 GMT The documentation underscores the value of immunization strategies in reducing severe disease outcomes within affected communities. Regional variations in coverage indicate opportunities for targeted outreach initiatives to improve community protection. Tick-borne encephalitis Vaccination Vaccine effectiveness Climate and environment Case-control study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-128076-2ff326f2/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-128076-2ff326f2/ Thu, 01 Jan 2026 00:00:00 GMT The article highlights a coverage–effectiveness paradox in older adults and outlines candidate policy and platform-level strategies to improve influenza vaccine outcomes in South Korea, with potential global relevance. Influenza Vaccination Vaccine effectiveness Surveillance Journal article https://globalinfectiousdisease.com/research/articles/10-1056-nejmsa2514268-02817cc7/ https://globalinfectiousdisease.com/research/articles/10-1056-nejmsa2514268-02817cc7/ Thu, 04 Dec 2025 00:00:00 GMT The review addresses disrupted U.S. vaccine advisory processes by providing an independent evidence base to support immunization decisions against major respiratory viruses for the 2025–2026 season. COVID-19 Influenza Vaccination Vaccine effectiveness Health policy Systematic review https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2025-30-46-2500854-cd6bca78/ https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2025-30-46-2500854-cd6bca78/ Thu, 20 Nov 2025 00:00:00 GMT These results suggest that current immunization strategies maintain their utility in mitigating healthcare burden during periods of emerging viral drift, supporting continued public health recommendations for seasonal prophylaxis. Influenza H5N1 Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41591-025-03998-9-b96e01f9/ https://globalinfectiousdisease.com/research/articles/10-1038-s41591-025-03998-9-b96e01f9/ Tue, 07 Oct 2025 00:00:00 GMT Findings from the abstract suggest Rotavac provided substantial protection against severe rotavirus disease under programmatic conditions in India, including against non-vaccine strains, and was characterized as performing comparably to internationally licensed vaccines in similar settings. Gastroenteritis SARS COVID-19 Vaccination Vaccine effectiveness Surveillance Case-control study https://globalinfectiousdisease.com/research/articles/10-1111-irv-70149-8eb09af5/ https://globalinfectiousdisease.com/research/articles/10-1111-irv-70149-8eb09af5/ Wed, 10 Sep 2025 00:00:00 GMT The data suggest that routine immunization programs help mitigate the volume of severe respiratory cases necessitating acute hospitalization across multiple age demographics. Influenza Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00018-0-0c50fdeb/ https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00018-0-0c50fdeb/ Tue, 01 Jul 2025 00:00:00 GMT The article provides Germany-specific observational evidence on MVA-BN safety and estimated effectiveness in the population studied during the 2022-2023 mpox period. Its findings may inform editorial context about vaccination evidence, including the reported difference in estimated effectiveness by HIV status, but they do not establish causality or confirm a current surveillance pattern. Smallpox Monkeypox Vaccination Vaccine effectiveness Outbreak investigation Transmission dynamics Cohort study https://globalinfectiousdisease.com/research/articles/10-1111-irv-70023-87fbe51b/ https://globalinfectiousdisease.com/research/articles/10-1111-irv-70023-87fbe51b/ Mon, 02 Dec 2024 00:00:00 GMT Continued emphasis on seasonal immunization remains critical for safeguarding vulnerable demographics and pediatric cohorts. Public health initiatives should persist in highlighting documented protective outcomes to sustain coverage rates among eligible groups. Influenza Vaccination Vaccine effectiveness Surveillance Case-control study https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciae537-f9190b11/ https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciae537-f9190b11/ Mon, 04 Nov 2024 00:00:00 GMT Routine infant immunization below the eight-and-a-half-month threshold may undermine sustained community-level protection, reinforcing recommendations to reserve early dosing for emergency outbreak response or elevated exposure environments. Mumps Rubella Measles Vaccination Treatment Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1093-eurpub-ckae144-1924-adff930a/ https://globalinfectiousdisease.com/research/articles/10-1093-eurpub-ckae144-1924-adff930a/ Mon, 28 Oct 2024 00:00:00 GMT Sustaining routine immunization initiatives appears capable of reducing outpatient utilization for influenza-related illnesses, with notably stronger protective signals observed when administering live attenuated formulations to school-aged youth. Influenza Vaccination Vaccine effectiveness Surveillance Case-control study https://globalinfectiousdisease.com/research/articles/10-1111-irv-70007-01fcf411/ https://globalinfectiousdisease.com/research/articles/10-1111-irv-70007-01fcf411/ Wed, 25 Sep 2024 00:00:00 GMT The article provides Queensland-specific evidence on influenza activity and vaccine effectiveness during a year when vaccination was publicly funded for all residents. It also reports outcome-specific and age-specific effectiveness estimates, including estimates for hospitalisation. Influenza Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41541-024-00960-7-38d314c4/ https://globalinfectiousdisease.com/research/articles/10-1038-s41541-024-00960-7-38d314c4/ Fri, 13 Sep 2024 00:00:00 GMT The findings support vaccination strategies by demonstrating that despite modest increases in post-vaccination thromboembolic risk, the overall effect of mRNA COVID-19 vaccination reduces thromboembolic event burden through prevention of infection-associated events, with greater benefit during high transmission periods. COVID-19 SARS Vaccination Outbreak investigation Vaccine effectiveness Case-control study https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-24-00143-9-c153178e/ https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-24-00143-9-c153178e/ Thu, 01 Aug 2024 00:00:00 GMT The paper provides context for tuberculosis vaccine development by describing a controlled human infection model intended for future evaluation of vaccine efficacy and potential correlates of protection. It does not provide evidence about population-level tuberculosis surveillance or current disease activity. Tuberculosis Vaccination Treatment Vaccine effectiveness Randomised controlled trial https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-18-2300558-9973be5c/ https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-18-2300558-9973be5c/ Thu, 02 May 2024 00:00:00 GMT The findings support vaccination recommendations by demonstrating that even young children can experience severe TBE and that complete vaccination provides durable protection against neurological disease for at least 10 years. Tick-borne encephalitis Surveillance Vaccination Vaccine effectiveness Case-control study